Publikationer

PubMed Agneta Siegbahn

Avhandlingar 

Ett urval av våra publikationer

Grundforskning

Aberg M, Johnell M, Wickström M, Siegbahn A. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1). Thromb Res. 2011 Feb;127(2):141-8.

Ringvall M, Thulin Å, Zhang L, Cedervall J, Tsuchida-Straeten N, Jahnen-Dechent W, Siegbahn A, Olsson AK. Enhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoprotein. PLoS One. 2011 Jan 17;6(1):e14526.

Uronen RL, Lundmark P, Orho-Melander M, Jauhiainen M, Larsson K, Siegbahn A, Wallentin L, Zethelius B, Melander O, Syvänen AC, Ikonen E. Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levels. Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1614-20.

Klinisk forskning

Christersson C, Oldgren J, Wallentin L, Siegbahn A. Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction. J Intern Med. 2011 Jan 22. doi: 10.1111/j.1365-2796.2011.02354.x.

Eggers KM, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Jantzen F, Peter T, Allhoff T, Siegbahn A, Venge P, Wollert KC, Wallentin L. Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome. Circ Cardiovasc Genet. 2010 Feb 1;3(1):88-96.

Alström U, Granath F, Oldgren J, Ståhle E, Tydén H, Siegbahn A. Platelet

inhibition assessed with VerifyNow, flow cytometry and Platelet Mapping in

patients undergoing heart surgery. Thromb Res. 2009 Nov;124(5):572-7.

Böcker och översiktsartiklar 

European Society of Cardiology POSITION PAPER:

De Caterina R, Husted S, Wallentin L, Agnelli G, Bachmann F, Baigent C, Jespersen J, Dalby Kristensen S, Montalescot G, Siegbahn A,W.A. Verheugt F, Weitz J: Anticoagulants in heart disease: current status and perspectives. Eur. Heart J. 2007;28:880 - 913

Siegbahn A. Patogenes vid akut kranskärlssjukdom; koagulation, fibrinolys; trombosmekanismer. In Akut kranskärlssjukdom. ( Major revision of previous chapter). Ed. Wallentin L. Tredje upplagan. CASAB 2005.

Siegbahn A. Patofysiologi vid venös insufficiens; koagulation och fibrinolys. Trombospatogenes. Vensjukdomar- Nordisk lärobok. Ed. Norgren L. Studentlitteratur. 2004